FDMT - 4D Molecular Therapeutics, Inc. -  [ ]

Seasonality of Returns By Period

Average daily return by calendar bucket (ClosePriceSA).

Day of Week

Week of Month

Month of Year

Seasonal Path

YTD vs Last Year vs Lookback Avg · closes rebased to 100 at each year's first session
Ticker Details
4D Molecular Therapeutics, Inc.
IPO Date: December 11, 2020
Sector: Healthcare
Industry: Biotech
Market Cap: $695.52M
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.63 | 3.89%
Avg Daily Range (30 D): $0.46 | 3.20%
Avg Daily Range (90 D): $0.49 | 4.03%
Institutional Daily Volume
Avg Daily Volume: .48M
Avg Daily Volume (30 D): .77M
Avg Daily Volume (90 D): .75M
Trade Size
Avg Trade Size (Sh.): 75
Avg Trade Size (Sh.) (30 D): 68
Avg Trade Size (Sh.) (90 D): 67
Institutional Trades
Total Institutional Trades: 1,347
Avg Institutional Trade: $1.79M
Avg Institutional Trade (30 D): $1.87M
Avg Institutional Trade (90 D): $2.01M
Avg Institutional Trade Volume: .12M
Avg Institutional Trades (Per Day): 1
Market Closing Trades
Avg Closing Trade: $1.74M
Avg Closing Trade (30 D): $2.38M
Avg Closing Trade (90 D): $1.93M
Avg Closing Volume: 110.31K
 
News
Aug 25, 2026 @ 12:00 PM
4DMT to Participate in Upcoming Investor Conferenc...
Source: Na
Jul 18, 2026 @ 7:15 PM
4DMT Announces Positive 2-Year Data from PRISM Pha...
Source: Not Specified
Jun 29, 2026 @ 12:00 PM
4DMT Secures Strategic Credit Facility for up to $...
Source: Na
Jun 18, 2026 @ 5:00 PM
Age-related Macular Degeneration Clinical Trial Pi...
Source: Delveinsight
Feb 19, 2026 @ 1:00 PM
4DMT to Participate in Upcoming Investor Conferenc...
Source: Na
Financials
  TTM Q2 2026 Q1 2026
Basic EPS $-2.63 $-1.04 $-1.01
Diluted EPS $-2.63 $-1.04 $-1.01
Revenue $92.01M $3.78M $3.05M
Gross Profit
Net Income / Loss $-179.18M $-72.94M $-68.76M
Operating Income / Loss $-197.12M $-77.03M $-73.62M
Cost of Revenue
Net Cash Flow $-6.79M $-2.12M $12.25M
PE Ratio